Role of the capsule in microglial cell-Cryptococcus neoformans interaction: Impairment of antifungal activity but not of secretory functions

Medical Mycology

Volumn 36, Issue 4, 1998, Pages 189-197

  Barluzzi, R ^a   Brozzetti, A ^a   Delfino, D ^b   Bistoni, F ^a   Blasi, E ^a,c  

^a UNIVERSITY OF PERUGIA   (Italy)

^b UNIVERSITY OF MESSINA   (Italy)

^c UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Capsule; Cryptococcus neoformans; Interaction; Microglia

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA; VIRULENCE FACTOR;

ANIMAL CELL; ARTICLE; CELL ADHESION; CELL LINE; CELL WALL; CONTROLLED STUDY; CRYPTOCOCCUS NEOFORMANS; IN VITRO STUDY; MICROGLIA; MUTANT; MYCOSIS; NONHUMAN; PHAGOCYTOSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; CELL LINE; CRYPTOCOCCUS NEOFORMANS; GENE EXPRESSION REGULATION; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; INTERLEUKIN-1; INTERLEUKIN-12; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MICE; MICROGLIA; PHAGOCYTOSIS; TRANSCRIPTION, GENETIC; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA; FILOBASIDIELLA NEOFORMANS; MURINAE;

EID: 33746436182     PISSN: 13693786     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-280X.1998.00126.x     Document Type: Article

References (42)

1. Kovacs JA, Kovacs AA, Polis M, et al. Cryptococcosis in the acquired immunodeficiency syndrome. Ann Intern Med 1985; 103: 533-8.
2. Pietroski NA, Stern JJ. Cryptococcal meningitis and other fungal infections of the central nervous system. Curr Opin Infect Dis 1990; 3: 608-13.
3. Kozel TR, Gotschlich EC. The capsule of Cryptococcus neoformans passively inhibits phagocytosis of the yeast by macrophages. J Immunol 1982; 129: 1675-80.
4. Collins HL, Bancroft GJ. Encapsulation of Cryptococcus neoformans impairs antigen-specific T-cell responses. Infect Immun 1991; 59: 3883-8.
5. Kwong-Chung KJ, Bennett JE. Cryptococcosis. In Medical Mycology. Philadelphia PA: Lea & Febiger, 1992: 397-446.
6. Cherniak R, Morris LC, Anderson BC, Meyer SA. Facilitated isolation, purification, and analysis of glucuronoxylomannan of Cryptococcus neoformans. Infect Immun 1991; 59: 59-64.
7. Turner SH, Cherniak R, Reiss E. Fractionation and characterization of galactoxylomannan from Cryptococcus neoformans. Carbohydr Res 1984; 125: 342-9.
8. James PG, Cherniak R. Galactoxylomannans of Cryptococcus neoformans. Infect Immun 1992; 60: 1084-8.
9. van de Moer A, Salhi SL, Cherniak R, et al. An anti-Cryptococcus neoformans monoclonal antibody directed against galactoxylomannan. Res Immunol 1990; 141: 33-42.
10. James PG, Cherniak R, James RG, Stortz CA, Reiss E. Cell-wall glucans of Cryptococcus neoformans CAP67. Carbohydr Res 1990; 198: 23-38.
11. Kozel TR, Pfrommer ST, Guerlain AS, Highison BA, Highison GJ. Strain variation in phagocytosis of Cryptococcus neoformans: dissociation of susceptibility to phagocytosis from activation and binding of opsonic fragments of C3. Infect Immun 1988; 56: 2794-800.
12. Levitz SM, Tabuni A. Binding of Cryptococcus neoformans by human cultured macrophages. Requirements for multiple complement receptors and actin. J Clin Invest 1991; 87: 528-35.
13. Mukherjee J, Scharff MD, Casadevall A. Protective murine monoclonal antibodies to Cryptococcus neoformans. Infect Immun 1992; 60: 4534-41.
14. Murphy JW, Hidore MR, Wong SC. Direct interactions of human lymphocytes with the yeast-like organism, Cryptococcus neoformans. J Clin Invest 1993; 91: 1553-66.
15. Cherniak R, Sundstrom JB. Polysaccharide antigens of the capsule of Cryptococcus neoformans. Infect Immun 1994; 62: 1507-12.
16. Mazzolla R, Barluzzi R, Romani L, Mosci P, Bistoni F. Anti-Candida resistance in the mouse brain and effect of intracerebral administration of interleukin-1. J Gen Microbiol 1991; 137: 1799-804.
17. Blasi E, Barluzzi R, Mazzolla R, Mosci P, Bistoni F. Experimental model of intracerebral infection with Cryptococcus neoformans: roles of phagocytes and opsonization. Infect Immun 1992; 60: 3682-8.
18. Fabry Z, Raine CS, Hart MN. Nervous tissue as an immune compartment: the dialect of the immune response in the CNS. Immunol Today 1994; 15: 218-24.
19. Blasi E, Barluzzi R, Mazzolla R, Bistoni F. Differential host susceptibility to intracerebral infections with Candida albicans and Cryptococcus neoformans. Infect Immun 1993; 61: 3476-81.
20. Blasi E, Barluzzi R, Mazzolla R, et al. Role of nitric oxide and melanogenesis in the accomplishment of anticryptococcal activity by the BV-2 microglial cell line. J Neuroimmunol 1995; 58: 111-16.
21. Lee SC, Dickson DW, Brosnan CF, Casadevall A. Human astrocytes inhibit Cryptococcus neoformans growth by a nitric oxide-mediated mechanism. J Exp Med 1994; 180: 365-9.
22. Blasi E, Barluzzi R, Bocchini V, Mazzolla R, Bistoni F. Immortalization of murine microglial cells by v-rafv-myc carrying retrovirus. J Neuroimmunol 1990; 27: 229-37.
23. Levitz SM. Activation of human peripheral blood mononuclear cells by interleukin-2 and granulocyte-macrophage colony-stimulating factor to inhibit Cryptococcus neoformans. Infect Immun 1991; 59: 3393-7.
24. Delfino D, Cianci L, Migliardo M, et al. Tumor necrosis factor-inducing activities of Cryptococcus neoformans components. Infect Immun 1996; 64: 5199-204.
25. Dubois M, Gilles KA, Hamilton JK, Rebers PA, Smith F. Colorimetric method for determination of sugars and related substances. Anal Chem 1956; 28: 350-6.
26. Murphy JW, Mosely RL, Cherniak R, et al. Serological, electrophoretic, and biological properties of Cryptococcus neoformans antigens. Infect Immun 1988; 56: 424-31.
27. Dong ZM, Murphy JW. Mobility of human neutrophils in response to Cryptococcus neoformans cells, culture filtrate antigen, and individual components of the antigen. Infect Immun 1993; 61: 5067-77.
28. Mancuso G, Tomasello F, von Hunolstein C, Orefici G, Teti G. Induction of tumor necrosis factor alpha by the group- and type-specific polysaccharides from type III group B streptococci. Infect Immun 1994; 62: 2748-53.
29. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-9.
30. Caput D, Beutler B, Hartog K, et al. Identification of a common nucleotide sequence in the 3′-untranslated region of mRNA molecules specifying inflammatory mediators. Proc Natl Acad Sci USA 1986; 83: 1670-4.
31. March CJ, Mosley B, Larsen A, et al. Cloning, sequence and expression of two distinct human interleukin-1 complementary DNAs. Nature 1985; 315: 641-7.
32. Rubin BY, Anderson SL, Sullivan SA, et al. Purification and characterization of a human tumor necrosis factor from the Luk II cell line. Proc Natl Acad Sci USA 1985; 82: 6637 41.
33. Blasi E, Puliti M, Pitzurra L, et al. Comparative studies on functional and secretory properties of macrophage cell lines derived from different anatomical sites. FEMS Immunol Med Microbiol 1994; 9: 207-15.
34. Dickson DW, Mattiace LA, Kure K, et al. Microglia in human disease, with an emphasis on acquired immune deficiency syndrome. Lab Invest 1991; 64: 135-56.
35. Giulian D, Baker TJ, Shih LC, Lachman LB. Interleukin-1 of the central nervous system is produced by ameboid microglia. J Exp Med 1986; 164: 594-604.
36. Giulian D. Ameboid microglia as effectors of inflammation in the central nervous system. J Neurosci Res 1987; 18: 155-71.
37. Frei K, Siepl C, Groscurth P, et al. Antigen presentation and tumor eytotoxicity by interferon-γ-treated microglial cells. Eur J Immunol 1987; 17: 1271-8.
38. Chao CC, Anderson WR, Hu S, et al. Activated microglia inhibit multiplication of Toxoplasma gondii via a nitric oxide mechanism, Clin Immunol Immunopathol 1993; 67: 178-83.
39. Bulmer GS, Sans MD. Cryptococcus neoformans. III. Inhibition of phagocytosis. J Bacteriol 1968; 95: 5-8.
40. Collins HL, Bancroft GJ. Cytokine enhancement of complement-dependent phagocytosis by macrophages: synergy of tumor necrosis factor-α and granulocyte-macrophage colony-stimulating factor for phagocytosis of Cryptococcus neoformans. Eur J Immunol 1992; 22: 1447-54.
41. Levitz SM, Tabuni A, Kornfeld H, Reardon CC, Golenbock DT. Production of tumor necrosis factor alpha in human leukocytes stimulated by Cryptococcus neoformans. Infect Immun 1994; 62: 1975-81.
42. Vecchiarelli A, Retini C, Pietrella D, et al. Downregulation by cryptococcal polysaccharide of tumor necrosis factor alpha and interleukin-1β secretion from human monocytes. Infect Immun 1995; 63: 2919-23.